Out-of-pocket costs play major role in treatment adherence for cancer patients

The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient's share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.

Fuente : http://www.eurekalert.org/pub_releases/2014-01/uon...